GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-137043 | Others
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Gastroesophageal reflux disease (GERD) drugs and instruments Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET
7.1 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND INSTRUMENTS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Jeil Pharmaceutical Co Ltd
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Eisai Co
16.3 Medtronic Inc
16.4 Mederi Therapeutics Inc
16.5 EndoStim Inc
16.6 Takeda Pharmaceutical
16.7 Bausch Health
16.8 Novartis AG
16.9 Torax Medical
16.10 Pfizer Inc
16.11 Cempra Inc
16.12 Johnson & Johnson
16.13 Teva Pharmaceuticals Industries
16.14 Medigus Ltd
16.15 Ironwood Pharmaceuticals
16.16 Merck
16.17 GlaxoSmithKline Plc
16.18 EndoGastric Solutions Inc
16.19 Boston Scientific Corporation
16.20 AstraZeneca PLC
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredAntacid
Stretta
Prodynamic agent
Bravo system
Linx Backflow Management System
Proton pump inhibitor
H2 receptor blocker
other
Medigus ultrasonic surgical intravascular fixator
24h pH impedance monitor
Major Downstream Industry Covered
Heartburn
Gastric acid reflux disorder
Companies
Jeil Pharmaceutical Co Ltd
Eisai Co
Medtronic Inc
Mederi Therapeutics Inc
EndoStim Inc
Takeda Pharmaceutical
Bausch Health
Novartis AG
Torax Medical
Pfizer Inc
Cempra Inc
Johnson & Johnson
Teva Pharmaceuticals Industries
Medigus Ltd
Ironwood Pharmaceuticals
Merck
GlaxoSmithKline Plc
EndoGastric Solutions Inc
Boston Scientific Corporation
AstraZeneca PLC
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.